HTFL Stock: Price, Forecast, Financials & AI Analysis

Loading...

01/15 19:44

High

36.540

Open

35.000

VWAP

35.55

Vol

2.00

Mkt Cap

3.08B

Low

34.620

Amount

71.10

EV/EBITDA(TTM)

--

Total Shares

85.16M

EV

2.69B

EV/OCF(TTM)

--

P/S(TTM)

--

HeartFlow Inc. is a commercial-stage medical technology company that has pioneered the use of software and artificial intelligence (AI) to deliver a non-invasive solution for diagnosing and managing coronary artery disease (CAD). The Company’s novel HeartFlow Platform uses AI and advanced computational fluid dynamics to create a personalized three-dimensional (3D) model of a patient’s heart based on a single coronary computed tomography angiography (CCTA). Its AI-driven platform includes Roadmap Analysis, FFRCT Analysis and Plaque Analysis. The HeartFlow FFRCT Analysis and Plaque Analysis software assists physicians in diagnosing, managing and delivering precision care to patients with CAD. The RoadMap Analysis offers a highly intuitive anatomic visualization of the coronary arteries, helping physicians quickly identify clinically relevant areas to focus their review.

Show More

Events Timeline

(ET)

2026-01-06

08:20:00

Heartflow Secures Full Coverage for Plaque Analysis by Aetna

2025-12-18 (ET)

2025-12-18

16:30:00

Heartflow Receives ACC and AHA Support for Prognostic Value of Coronary Plaque Quantification

2025-11-12 (ET)

2025-11-12

16:28:21

Heartflow projects FY25 revenue between $173M and $173.5M, surpassing consensus estimate of $165.97M.

2025-11-12

16:27:14

Heartflow announces Q3 earnings per share of 27 cents, surpassing consensus estimate of 24 cents.

2025-11-09 (ET)

2025-11-09

13:34:03

Heartflow Reveals Findings from FISH&CHIPS Study on Heartflow Plaque Analysis

2025-10-22 (ET)

2025-10-22

08:16:39

Heartflow Launches Heartflow PCI Navigator

News

an image of Globenewswire

01-05Globenewswire

Heartflow to Present AI Technology at 44th J.P. Morgan Healthcare Conference

an image of Fool

HeartFlow Board Member Jeffrey Lightcap Acquires 40,000 Shares for $1.05 Million

an image of NASDAQ.COM

2025-12-28NASDAQ.COM

HeartFlow Director Jeffrey Lightcap Acquires 40,000 Shares for $1.05 Million

an image of Yahoo Finance

2025-12-28Yahoo Finance

HeartFlow Director Lightcap Acquires 40,000 Shares for Over $1 Million

an image of Yahoo Finance

2025-12-24Yahoo Finance

Navan IPO Raises $923 Million; Insider Buys 100,000 Shares

an image of Globenewswire

2025-12-18Globenewswire

Heartflow Receives ACC and AHA Endorsement for AI Coronary Plaque Analysis

5 Analyst Rating

Wall Street analysts forecast HTFL stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HTFL is 38.60 USD with a low forecast of 35.00 USD and a high forecast of 40.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

4 Buy

1 Hold

0 Sell

Strong Buy

Current: 0.000

Low

35.00

Averages

38.60

High

40.00

Current: 0.000

Low

35.00

Averages

38.60

High

40.00

Canaccord

Buy

maintain

$39 -> $40

Al Analysis

2025-11-13

Reason

Canaccord

Price Target

$39 -> $40

Al Analysis

2025-11-13

maintain

Buy

Reason

Canaccord raised the firm's price target on Heartflow to $40 from $39 and keeps a Buy rating on the shares. The firm said HeartFlow delivered a strong Q3/25 beat fresh out of the IPO gate and formally issued guidance ahead of estimates, but very conservative.

JPMorgan

Robbie Marcus

Overweight

maintain

$36 -> $40

2025-11-13

Reason

JPMorgan

Robbie Marcus

Price Target

$36 -> $40

2025-11-13

maintain

Overweight

Reason

JPMorgan analyst Robbie Marcus raised the firm's price target on Heartflow to $40 from $36 and keeps an Overweight rating on the shares. The firm views the company's Q3 report as strong.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for HTFL

Unlock Now

Valuation Metrics

The current forward P/E ratio for Heartflow Inc (HTFL.O) is -54.63, compared to its 5-year average forward P/E of -53.74. For a more detailed relative valuation and DCF analysis to assess Heartflow Inc 's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

an image of dotted line Image

N/A

5Y Average PE

-53.74

Current PE

-54.63

Overvalued PE

-44.06

Undervalued PE

-63.41

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

an image of dotted line Image

N/A

5Y Average EV/EBITDA

-61.34

Current EV/EBITDA

-43.69

Overvalued EV/EBITDA

-44.85

Undervalued EV/EBITDA

-77.83

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

an image of dotted line Image

5Y Average PS

13.68

Current PS

12.35

Overvalued PS

16.04

Undervalued PS

11.32

Financials

Al Analysis

Annual

Quarterly

Trading Trends

People Also Watch

Frequently Asked Questions

What is Heartflow Inc (HTFL) stock price today?

The current price of HTFL is 36.12 USD — it has increased 3.26 % in the last trading day.

What is Heartflow Inc (HTFL)'s business?

HeartFlow Inc. is a commercial-stage medical technology company that has pioneered the use of software and artificial intelligence (AI) to deliver a non-invasive solution for diagnosing and managing coronary artery disease (CAD). The Company’s novel HeartFlow Platform uses AI and advanced computational fluid dynamics to create a personalized three-dimensional (3D) model of a patient’s heart based on a single coronary computed tomography angiography (CCTA). Its AI-driven platform includes Roadmap Analysis, FFRCT Analysis and Plaque Analysis. The HeartFlow FFRCT Analysis and Plaque Analysis software assists physicians in diagnosing, managing and delivering precision care to patients with CAD. The RoadMap Analysis offers a highly intuitive anatomic visualization of the coronary arteries, helping physicians quickly identify clinically relevant areas to focus their review.

What is the price predicton of HTFL Stock?

Wall Street analysts forecast HTFL stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HTFL is38.60 USD with a low forecast of 35.00 USD and a high forecast of 40.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Heartflow Inc (HTFL)'s revenue for the last quarter?

Heartflow Inc revenue for the last quarter amounts to 46.28M USD, increased 40.51 % YoY.

What is Heartflow Inc (HTFL)'s earnings per share (EPS) for the last quarter?

Heartflow Inc. EPS for the last quarter amounts to -1.04 USD, increased 333.33 % YoY.

How many employees does Heartflow Inc (HTFL). have?

Heartflow Inc (HTFL) has 699 emplpoyees as of January 16 2026.

What is Heartflow Inc (HTFL) market cap?

Today HTFL has the market capitalization of 3.08B USD.